Financhill
Back

VictoryShares US SmCp High Div Vol Wtd ETF Vs. Cidara Therapeutics Industry Stock Comparison

Buy
64

CSB
VictoryShares US SmCp High Div Vol Wtd ETF

Last Price:
$56.35
Seasonality Move:
-1.93%
Buy
77

CDTX
Cidara Therapeutics

Last Price:
$62.00
Seasonality Move:
2.01%
Buy
64
VictoryShares US SmCp High Div Vol Wtd ETF (CSB) is a Buy

Is VictoryShares US SmCp High Div Vol Wtd ETF a Buy, Sell or Hold?

  • The current VictoryShares US SmCp High Div Vol Wtd ETF [CSB] share price is $57.64. The Score for CSB is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • CSB is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
77
Cidara Therapeutics (CDTX) is a Buy

Is Cidara Therapeutics a Buy, Sell or Hold?

  • The current Cidara Therapeutics [CDTX] share price is $62.00. The Score for CDTX is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
  • CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CSB Stock Price Chart

What is VictoryShares US SmCp High Div Vol Wtd ETF's stock price today?

  • The VictoryShares US SmCp High Div Vol Wtd ETF share price today is $57.64
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CSB is experiencing buying pressure, which is a positive indicator for future bullish movement.

CDTX Stock Price Chart

What is Cidara Therapeutics's stock price today?

  • The Cidara Therapeutics share price today is $62.00
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing slight selling pressure.

CSB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 15.27 Buy
Relative Strength Index (14 RSI): 58.59 Buy
Chaikin Money Flow: 23734 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (56.2 - 57.66) Buy
Bollinger Bands (100): (53.72 - 57.26) Buy

CDTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 16.72 Buy
Relative Strength Index (14 RSI): 66.1 Buy
Chaikin Money Flow: -71329 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.74 - 63.84) Buy
Bollinger Bands (100): (16.87 - 51.01) Buy

CSB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.3 Buy
20-day SMA: 56.8 Buy
50-day SMA: 56.23 Buy
200-day SMA: 57.96 Sell
8-day EMA: 53 Buy
20-day EMA: 37.67 Buy
50-day EMA: 20.08 Buy
200-day EMA: 5.88 Buy

CDTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 62.11 Sell
20-day SMA: 61.15 Buy
50-day SMA: 46.89 Buy
200-day SMA: 27.08 Buy
8-day EMA: 58.14 Buy
20-day EMA: 41.46 Buy
50-day EMA: 22.13 Buy
200-day EMA: 6.48 Buy

VictoryShares US SmCp High Div Vol Wtd ETF Earnings Growth & CSB Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Cidara Therapeutics Earnings Growth & CDTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $4.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $16.92 per share, and a decrease next year of $1.83 per share.

VictoryShares US SmCp High Div Vol Wtd ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cidara Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):